Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Weight loss results from SURPASS-2: At the maximum 15 mg tirzepatide dose, patients lost nearly double the weight of those on semaglutide
Additionally, the peptide appears to interact with multiple growth factor receptors and signaling pathways involved in cellular migration, proliferation, and differentiation, all essential processes for tissue healing
Novo Nordisk reported net sales of $43.27 billion in 2025, with its obesity and weight-loss drugs accounting for a large percentage of its growth
Receptor Grade IGF-1 LR3 Longevity-Related Research Preclinical research has also explored IGF-1 LR3 in the context of tissue maintenance and survival
US$ 22.98
US$ 27.61
US$ 28.91
US$ 25.68
US$ 29.86
US$ 21.94
